Freeze-Dried Aripiprazole Cake Layout to Prevent Silicone Agglomeration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
The presence of silicone-treated inner walls in storage containers causes agglomeration of aripiprazole during long-term storage, leading to increased particle size and reduced dissolution rate, affecting drug efficacy and causing clogging and physical stimulus at the injection site.
Innovation Solution
A medical device with a silicone-treated inner wall and a space between the inner wall and the cake composition is used to minimize contact and mixing of silicone, inhibiting agglomeration and ensuring quick resuspension.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Ease of operation
If the storage container inner wall is treated with silicone to allow smooth sliding of sealing plugs, then the ease of operation is improved, but the aripiprazole particles agglomerate and mean particle size increases due to silicone mixing into the freeze-dried substance during long-term storage
Solution Approach 1:
The storage container is divided into two distinct spaces: a first space containing the freeze-dried cake composition and a second space containing the sealing plug. The silicone treatment is applied only to the inner wall of the second space, preventing direct contact between silicone and aripiprazole particles while maintaining smooth sliding functionality for the sealing plug.
Solution Approach 2:
A partition wall or spatial separation acts as an intermediary barrier between the silicone-treated surface and the aripiprazole cake composition. This prevents silicone migration into the freeze-dried substance while allowing the silicone to fulfill its lubrication function for the sealing plug.
2Duration of action of stationary object
If the cake composition is stored in the storage container for several months, then the storage duration is extended, but silicone mixes into the freeze-dried substance causing agglomeration and reduced dissolution rate
Solution Approach 1:
The storage container is segmented into separate compartments: one for the freeze-dried cake composition and another for the sealing plug with silicone treatment. This spatial segmentation allows long-term storage without silicone contamination of the aripiprazole particles, maintaining dissolution rate and particle size control throughout the storage period.
3Stability of the object's composition
If the cake composition contacts the silicone-treated inner wall during storage, then the storage stability is improved, but the aripiprazole particles undergo agglomeration and mean particle size increases
Solution Approach 1:
The storage container is divided into separate spaces: the first space holds the freeze-dried cake composition while the second space contains the sealing plug with silicone treatment. This segmentation maintains storage stability by preventing direct contact between aripiprazole particles and silicone, thereby controlling particle size and preventing agglomeration.
Solution Approach 2:
The partition or spatial separation serves as an intermediary that prevents silicone from migrating into the freeze-dried aripiprazole substance. This intermediary barrier maintains particle size control and prevents agglomeration while allowing the silicone to provide stability for the sealing plug during storage.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The solution effectively suppresses agglomeration, maintains particle size, and ensures consistent drug efficacy by reducing silicone contact, preventing clogging, and minimizing physical stimulus.
Implementation Method 1
the pharmaceutical composition is suspended in a dispersion medium, and the thus-obtained suspension is freeze-dried, thereby preparing a cake composition
Data Source
AI summary
The present invention provides a medical device containing a cake composition comprising aripiprazole as an active ingredient and capable of suppressing agglomeration of aripiprazole in a suspension obtained by resuspending a freeze-dried substance; and a cake composition comprising aripiprazole as an active ingredient. The present invention relates to a medical device containing, in a storage container whose inner wall is treated with silicone, a freeze-dried cake composition comprising separately prepared aripiprazole as an active ingredient, wherein there is a space between the inner wall and the cake composition; and a cake composition comprising aripiprazole as an active ingredient and having a strength of 5 to 100 N.


